Inspire Terminates Deal With FAES Farma For Oral Bilastine

Company ends collaboration following a meeting with FDA last year in which the agency recommended additional clinical trial work.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet